Savara Inc. Share Price & Technical Analysis
SVRA · $5.14
Healthcare / Biotechnology
$5.14
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Langhorne, …
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-2% return in May, 2% avg return in past 3 year May month.
-13% return in 2026, 74% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -10% | 11% | -7% | -5% | -2% | – | – | – | – | – | – | – | -13% |
| 25 | -13% | -4% | 12% | 10% | -28% | -4% | 13% | 27% | 9% | 20% | 50% | 5% | 98% |
| 24 | 4% | 2% | -2% | -8% | -13% | -2% | 12% | -9% | 0% | -14% | -8% | -6% | -44% |
| 23 | 73% | 0% | -20% | 0% | 47% | 19% | 13% | 3% | 6% | -3% | 6% | 24% | 167% |
| 22 | -8% | 0% | 18% | -8% | 8% | 15% | 7% | -12% | 7% | -20% | 33% | -6% | 35% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Emerging · Neutral
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Langhorne, Pennsylvania.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.03B
P/E ratio
—
52W high
$7.01
52W low
$1.89
Beta
0.28
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Savara Inc. share price today?
- Savara Inc. (SVRA) last traded around $5.14 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does SVRA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for SVRA. Download the app for real-time alerts.
- How can I analyze Savara Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.